Stress Trajectories and Anhedonia in Adolescence Research Study
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Jun 18, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This study is looking at how the brain and body respond to stress in teenagers, and how these responses might be linked to anhedonia—a condition where someone finds it hard to feel pleasure or enjoy things. Researchers want to understand if different patterns in brain activity and stress responses can explain why some adolescents develop anhedonia and how it changes over time.
The study is open to teens aged 13 to 15 who can understand and agree to take part. Over about 20 months, participants will visit the research team three times. During these visits, they’ll complete surveys, provide saliva samples to check hormone levels, have brain scans, and take part in mild stress tests and thinking activities. Parents or guardians will also be asked to fill out some surveys. The study is carefully designed to include only teens without certain medical conditions or medications that could affect the results. This research hopes to better understand how stress affects young people’s ability to enjoy life, which could help improve future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 13-15 years old at study entry
- • Ability to understand and sign an assent form
- • Meets study hearing and vision requirements
- Exclusion Criteria:
- • Current use of antipsychotic medication
- • Current use of medications that would interfere with cardiovascular or endocrine assessments
- • Metal in the body or other MRI exclusion
- • Central nervous system disorder or brain injury that could confound brain imaging evaluations
- • Presence of a medical condition that would interfere with cardiovascular or endocrine assessments
- • Impaired intellectual functioning
- • Diagnosed with a neurodevelopmental disability
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Aysenil Belger, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Danielle Roubinov, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported